Search Results
Found 1 results
510(k) Data Aggregation
(87 days)
The test is for the quantitative measurement of the IgG class of auto-antibodies to anti-Thyroglobulin (anti-Tg) in human serum or plasma (EDTA or heparin) to aid in the diagnosis of thyroid disease
Abbott AxSYM® anti-Thyroglobulin (anti-Tg) Microparticle Enzyme Immunoassay (MEIA)
This document is a 510(k) premarket notification letter from the FDA to Axis-Shield Diagnostics Ltd. regarding the Abbott AxSYM® anti-Thyroglobulin (anti-Tg) Microparticle Enzyme Immunoassay (MEIA). It largely focuses on the regulatory approval process and states that the device is substantially equivalent to legally marketed predicate devices.
The document does not contain the specific information requested in the prompt regarding acceptance criteria, study details, sample sizes, expert qualifications, or ground truth establishment. This type of detailed performance data and study design information is typically found in the 510(k) summary or full submission, which is not provided in these pages.
Ask a specific question about this device
Page 1 of 1